Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Clinical trial NCT01532232 · TERMINATED

Trial details

NCT number: NCT01532232
Sponsor: Memorial Sloan Kettering Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Cancer Tobacco Dependence

Start date: 2012-02-01
Primary completion: 2014-10-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.